Treasurer of the State of North Carolina Buys 590 Shares of Enovis Co. (NYSE:ENOV)

Treasurer of the State of North Carolina raised its stake in Enovis Co. (NYSE:ENOV) by 2.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,347 shares of the company’s stock after acquiring an additional 590 shares during the quarter. Treasurer of the State of North Carolina’s holdings in Enovis were worth $1,068,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Aster Capital Management DIFC Ltd acquired a new position in shares of Enovis in the fourth quarter valued at approximately $29,000. Quadrant Capital Group LLC grew its holdings in Enovis by 53.0% in the 4th quarter. Quadrant Capital Group LLC now owns 690 shares of the company’s stock valued at $30,000 after buying an additional 239 shares in the last quarter. UMB Bank n.a. increased its position in Enovis by 128.2% during the 4th quarter. UMB Bank n.a. now owns 778 shares of the company’s stock worth $34,000 after buying an additional 437 shares during the period. Pinnacle Bancorp Inc. boosted its position in shares of Enovis by 54.5% in the fourth quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company’s stock valued at $37,000 after acquiring an additional 300 shares during the period. Finally, FMR LLC grew its stake in shares of Enovis by 20.5% in the third quarter. FMR LLC now owns 2,840 shares of the company’s stock valued at $122,000 after acquiring an additional 484 shares in the last quarter. 98.45% of the stock is currently owned by institutional investors and hedge funds.

Enovis Stock Performance

NYSE:ENOV opened at $31.91 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27. Enovis Co. has a fifty-two week low of $29.32 and a fifty-two week high of $56.89. The company has a market cap of $1.82 billion, a price-to-earnings ratio of -14.57 and a beta of 1.86. The stock has a fifty day moving average price of $37.78 and a 200-day moving average price of $42.23.

Enovis (NYSE:ENOV) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.92 by $0.06. The firm had revenue of $560.98 million for the quarter, compared to the consensus estimate of $555.14 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. As a group, equities analysts anticipate that Enovis Co. will post 2.79 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reiterated a “buy” rating and issued a $64.00 price objective on shares of Enovis in a research note on Wednesday, April 9th.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.